WebThis agent appears to have a marked effect on the kinetics of some commonly used cardiovascular drugs, such as warfarin, digoxin, quinidine, and procainamide, and has dynamic interactions with others, such as the beta blockers and some calcium antagonists. Webtolerated, either the strong CYP3A4 inhibitor must be discontinued, or SPRYCEL should be stopped until treatment with the inhibitor has ceased. When the strong inhibitor is …

SPRYCEL® (dasatinib) Dosing HCP

WebIn rare instances, Sprycel can cause more serious side effects. These can include: Feeling lightheaded or faint Tiredness, chest pain, shortness of breath Severe nausea, vomiting, diarrhea Severe headaches Rapid weight gain, swelling Irregular heartbeat Easily bruised, unusual bleeding, red or purple dotted skin rash WebSPRYCEL ® safely and effectively. See full prescribing information for ... stopped before the SPRYCEL dose is increased [see Drug Interactions (7.1)]. 2.4 Dose Escalation In clinical … spth free form

Reference ID: 4179887 - Food and Drug Administration

WebThis is a summary of the risk management plan (RMP) for SPRYCEL. The RMP details important risks of SPRYCEL, how these risks can be minimise, and how more information … WebSummary: Drug interactions are reported among people who take Flexeril and Sprycel. Common interactions include bacterial test positive among females and dyspnoea … WebCommon interactions include rash among females and nausea among males. The phase IV clinical study analyzes what interactions people who take Sprycel and Tylenol have. It is … spth form validation error